dc.contributor.author |
Rocca B. |
dc.contributor.author |
Morosetti R. |
dc.contributor.author |
Habib A. |
dc.contributor.author |
Maggiano N. |
dc.contributor.author |
Zassadowski F. |
dc.contributor.author |
Ciabattoni G. |
dc.contributor.author |
Chomienne C. |
dc.contributor.author |
Papp B. |
dc.contributor.author |
Ranelletti F.O. |
dc.contributor.editor |
|
dc.date |
Aug-2004 |
dc.date.accessioned |
2017-10-05T15:37:21Z |
dc.date.available |
2017-10-05T15:37:21Z |
dc.date.issued |
2004 |
dc.identifier |
10.1038/sj.leu.2403407 |
dc.identifier.isbn |
|
dc.identifier.issn |
08876924 |
dc.identifier.uri |
http://hdl.handle.net/10938/15650 |
dc.description.abstract |
Cyclooxygenase (COX)-1 or -2 and specific prostaglandin (PG) synthases catalyze the formation of various PGs. We investigated the expression and activity of COX-1 and -2 during granulocyte-oriented maturation induced by all-trans-retinoic acid (ATRA) of NB4 cells, originated from a human acute promyelocytic leukemia (APL), and in blasts from APL patients. The expression of COX isoenzymes or prostaglandin synthases was also investigated in circulating granulocytes and human bone marrow. COX-1 was expressed and enzymatically active in NB4 cells and primary blasts. COX-1 mRNA and protein were induced by ATRA. COX-1 protein increased approximately 2-3.5-fold by culture day 3 in NB4 cells and primary blasts, while basal COX-2 expression was very low and unaffected by ATRA. COX-1-dependent PGE2 biosynthesis increased during differentiation approx. 5-fold. Indomethacin and the selective COX-1 inhibitor SC-560, but not selective COX-2 inhibition, impaired NB4 differentiation, reducing NADPH-oxidase activity, CD11b and CD11c expression. The immunohistochemistry of granulocytes and myeloid precursors in the bone marrow showed a large prevalence of COX-1 as compared to COX-2. In conclusion, COX-1 is induced during ATRA-dependent maturation and appears to contribute to myeloid differentiation both in vitro and ex vivo, and COX-1 activity may potentiate the differentiation of human APL. © 2004 Nature Publishing Group All rights reserved. |
dc.format.extent |
|
dc.format.extent |
Pages: (1373-1379) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Leukemia; Publication Year: 2004; Volume: 18; no. 8; Pages: (1373-1379); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation |
dc.type |
Article |
dc.contributor.affiliation |
Rocca, B., Department of Internal Medicine, Catholic University School of Med., Largo A. Gemelli 8, 00168 Rome, Italy |
dc.contributor.affiliation |
Morosetti, R., Department of Neuroscience, Catholic University School of Med., Rome, Italy |
dc.contributor.affiliation |
Habib, A., Dept. of Biochem.-Internal Medicine, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Maggiano, N., Department of Pathology, Catholic University School of Med., Rome, Italy |
dc.contributor.affiliation |
Zassadowski, F., Lab. de Biol. Cell. Hematopoietique, Institut Universitaire d'Hematologie, Hôpital Saint-Louis, Paris, France |
dc.contributor.affiliation |
Ciabattoni, G., Department of Drug Sciences, G D'Annunzio Univ. of Chieti, Chieti, Italy |
dc.contributor.affiliation |
Chomienne, C., Lab. de Biol. Cell. Hematopoietique, Institut Universitaire d'Hematologie, Hôpital Saint-Louis, Paris, France |
dc.contributor.affiliation |
Papp, B., Lab. de Biol. Cell. Hematopoietique, Institut Universitaire d'Hematologie, Hôpital Saint-Louis, Paris, France |
dc.contributor.affiliation |
Ranelletti, F.O., Department of Histology, Catholic University School of Med., Rome, Italy |
dc.contributor.authorAddress |
Rocca, B.; Department of Internal Medicine, Ctr. Ricerche Fisiopatol. Emostasi, Università Cattolica, Largo A. Gemelli 8, 00168 Rome, Italy; email: b.rocca@tiscali.it |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
b.rocca@tiscali.it |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Rocca, B |
dc.contributor.authorInitials |
Morosetti, R |
dc.contributor.authorInitials |
Habib, A |
dc.contributor.authorInitials |
Maggiano, N |
dc.contributor.authorInitials |
Zassadowski, F |
dc.contributor.authorInitials |
Ciabattoni, G |
dc.contributor.authorInitials |
Chomienne, C |
dc.contributor.authorInitials |
Papp, B |
dc.contributor.authorInitials |
Ranelletti, FO |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Rocca, B (reprint author), Catholic Univ, Ctr Ric Fisiopatol Emostasi, Dept Internal Med, Sch Med, Largo A Gemelli 8, I-00168 Rome, Italy. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
BAZAN NG, 1994, P NATL ACAD SCI USA, V91, P5252, DOI 10.1073-pnas.91.12.5252; BERK LB, 1990, INT J RADIAT ONCOL, V18, P1387; Chen ZX, 1997, CHINESE MED J-PEKING, V110, P783; DATTA MC, 1985, PROSTAGLANDINS, V29, P561, DOI 10.1016-0090-6980(85)90080-2; Degraeve F, 2001, J BIOL CHEM, V276, P46849, DOI 10.1074-jbc.M104197200; DERTINGER SD, 1995, MUTAT RES-FUND MOL M, V328, P55, DOI 10.1016-0027-5107(94)00195-B; Dogne JM, 2001, CARDIOVASC DRUG REV, V19, P87; Duprez E, 1996, ONCOGENE, V12, P2451; Dupuis F, 1997, J LIPID MEDIAT CELL, V16, P117, DOI 10.1016-S0929-7855(97)00007-2; FONTAGNE J, 1980, EXP HEMATOL, V8, P1157; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016-0090-6980(94)90074-4; GIANNI M, 1995, BLOOD, V85, P3619; Goldschmidt N, 2003, LEUKEMIA LYMPHOMA, V44, P1433, DOI 10.1080-1042819031000076963; Gonchar MV, 1998, BIOCHEM BIOPH RES CO, V249, P829, DOI 10.1006-bbrc.1998.9236; HANSON WR, 1985, RADIAT RES, V103, P196, DOI 10.2307-3576574; HOFF T, 1993, FEBS LETT, V320, P38, DOI 10.1016-0014-5793(93)81653-H; HONDA A, 1986, BIOCHIM BIOPHYS ACTA, V877, P423, DOI 10.1016-0005-2760(86)90208-0; HONDA A, 1992, EUR J PHARMACOL, V229, P217; HONDA A, 1990, BIOCHEM J, V272, P259; Ishiguro S, 1998, PROSTAG OTH LIPID M, V56, P145, DOI 10.1016-S0090-6980(98)00051-3; Jiang LL, 1997, BIOCHEM BIOPH RES CO, V232, P626, DOI 10.1006-bbrc.1997.6345; Jiang YJ, 2003, BBA-MOL CELL BIOL L, V1633, P51, DOI 10.1016-S1388-1981(03)00072-6; Kastner P, 2001, ONCOGENE, V20, P7178, DOI 10.1038-sj.onc.1204757; Khanna-Gupta A, 2000, BLOOD, V95, P3734; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084-jem.187.4.517; Kwaan HC, 2002, HEMATOL ONCOL, V20, P33, DOI 10.1002-hon.687; Launay S, 1999, BLOOD, V93, P4395; Lee KH, 2002, BIOCHEM BIOPH RES CO, V296, P1125, DOI 10.1016-S0006-291X(02)02043-0; Lorenz M, 1999, EXP HEMATOL, V27, P1494, DOI 10.1016-S0301-472X(99)00087-9; Maloney CG, 1998, J IMMUNOL, V160, P1402; Morosetti R, 1997, BLOOD, V90, P2591; Murate T, 2002, J BIOL CHEM, V277, P9936, DOI 10.1074-jbc.M111594200; NUSING RM, 1995, EUR J BIOCHEM, V227, P130, DOI 10.1111-j.1432-1033.1995.tb20368.x; Ohno R, 2003, LEUKEMIA, V17, P1454, DOI 10.1038-sj.leu.2403031; PELUS LM, 1983, BLOOD, V62, P158; PIANTELLI M, 1983, CLIN IMMUNOL IMMUNOP, V28, P350, DOI 10.1016-0090-1229(83)90102-2; Pouliot M, 1998, FASEB J, V12, P1109; Quenech'Du N, 1998, LEUKEMIA, V12, P1829, DOI 10.1038-sj.leu.2401171; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172-JCI6400; Rocca B, 2002, EUR J IMMUNOL, V32, P1482, DOI 10.1002-1521-4141(200205)32:51482::AID-IMMU14823.0.CO;2-O; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016-S1567-5769(01)00204-1; Rocca B, 2002, P NATL ACAD SCI USA, V99, P7634, DOI 10.1073-pnas.112202999; Roussel MJS, 2001, ONCOGENE, V20, P7287, DOI 10.1038-sj.onc.1204863; RUCHAUD S, 1994, P NATL ACAD SCI USA, V91, P8428, DOI 10.1073-pnas.91.18.8428; SANDUJA SK, 1991, BLOOD, V78, P3178; Schneider N, 2001, J NEUROCHEM, V77, P416, DOI 10.1046-j.1471-4159.2001.00264.x; SELLMAYER A, 1994, PROSTAGLANDINS, V47, P203; SHIBATA Y, 1994, BLOOD, V83, P3316; SMITH CJ, 1993, BIOCHEM BIOPH RES CO, V192, P787, DOI 10.1006-bbrc.1993.1483; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073-pnas.95.22.13313; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172-JCI13271; Suzuki Y, 1999, BLOOD, V93, P4264; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074-jbc.M100429200; ULICH TR, 1986, AM J PATHOL, V124, P53; Xu XM, 1997, J BIOL CHEM, V272, P6943 |
dc.description.citedCount |
16 |
dc.description.citedTotWOSCount |
16 |
dc.description.citedWOSCount |
15 |
dc.format.extentCount |
7 |
dc.identifier.articleNo |
|
dc.identifier.coden |
LEUKE |
dc.identifier.pubmedID |
15190260 |
dc.identifier.scopusID |
4344614136 |
dc.identifier.url |
|
dc.publisher.address |
MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Leukemia |
dc.relation.ispartOfIssue |
8 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Leukemia |
dc.relation.ispartofPubTitleAbbr |
Leukemia |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
18 |
dc.source.ID |
WOS:000222821500009 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Acute promyelocytic leukemia |
dc.subject.otherAuthKeyword |
Cyclooxygenases |
dc.subject.otherAuthKeyword |
Granulocytes |
dc.subject.otherAuthKeyword |
Prostaglandins |
dc.subject.otherAuthKeyword |
Retinoic acid |
dc.subject.otherChemCAS |
5 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 trifluoromethyl 1h pyrazole, 188817-13-2 |
dc.subject.otherChemCAS |
indometacin, 53-86-1, 74252-25-8, 7681-54-1 |
dc.subject.otherChemCAS |
n (2 cyclohexyloxy 4 nitrophenyl)methanesulfonamide, 123653-11-2 |
dc.subject.otherChemCAS |
prostaglandin E2, 363-24-6 |
dc.subject.otherChemCAS |
prostaglandin synthase, 39391-18-9, 59763-19-8, 9055-65-6 |
dc.subject.otherChemCAS |
reduced nicotinamide adenine dinucleotide phosphate oxidase, 9032-22-8 |
dc.subject.otherChemCAS |
retinoic acid, 302-79-4 |
dc.subject.otherChemCAS |
Cyclooxygenase 1, EC 1.14.99.1 |
dc.subject.otherChemCAS |
Cyclooxygenase 2, EC 1.14.99.1 |
dc.subject.otherChemCAS |
Dinoprostone, 363-24-6 |
dc.subject.otherChemCAS |
Isoenzymes |
dc.subject.otherChemCAS |
Membrane Proteins |
dc.subject.otherChemCAS |
Prostaglandin-Endoperoxide Synthases, EC 1.14.99.1 |
dc.subject.otherChemCAS |
PTGS1 protein, human, EC 1.14.99.1 |
dc.subject.otherChemCAS |
PTGS2 protein, human, EC 1.14.99.1 |
dc.subject.otherChemCAS |
RNA, Messenger |
dc.subject.otherChemCAS |
Tretinoin, 302-79-4 |
dc.subject.otherIndex |
5 (4 chlorophenyl) 1 (4 methoxyphenyl) 3 trifluoromethyl 1h pyrazole |
dc.subject.otherIndex |
CD11b antigen |
dc.subject.otherIndex |
cyclooxygenase 1 |
dc.subject.otherIndex |
cyclooxygenase 1 inhibitor |
dc.subject.otherIndex |
cyclooxygenase 2 |
dc.subject.otherIndex |
cyclooxygenase 2 inhibitor |
dc.subject.otherIndex |
glycoprotein p 15095 |
dc.subject.otherIndex |
indometacin |
dc.subject.otherIndex |
isoenzyme |
dc.subject.otherIndex |
messenger RNA |
dc.subject.otherIndex |
n (2 cyclohexyloxy 4 nitrophenyl)methanesulfonamide |
dc.subject.otherIndex |
prostaglandin E2 |
dc.subject.otherIndex |
prostaglandin synthase |
dc.subject.otherIndex |
reduced nicotinamide adenine dinucleotide phosphate oxidase |
dc.subject.otherIndex |
retinoic acid |
dc.subject.otherIndex |
antigen expression |
dc.subject.otherIndex |
antineoplastic activity |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
bone marrow cell |
dc.subject.otherIndex |
cancer cell culture |
dc.subject.otherIndex |
cancer inhibition |
dc.subject.otherIndex |
cell differentiation |
dc.subject.otherIndex |
cell maturation |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
drug selectivity |
dc.subject.otherIndex |
enzyme activity |
dc.subject.otherIndex |
enzyme induction |
dc.subject.otherIndex |
enzyme inhibition |
dc.subject.otherIndex |
ex vivo study |
dc.subject.otherIndex |
granulocyte |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
human cell |
dc.subject.otherIndex |
immunohistochemistry |
dc.subject.otherIndex |
leukemia cell |
dc.subject.otherIndex |
leukemogenesis |
dc.subject.otherIndex |
myeloid progenitor cell |
dc.subject.otherIndex |
prevalence |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
promyelocyte |
dc.subject.otherIndex |
promyelocytic leukemia |
dc.subject.otherIndex |
prostaglandin synthesis |
dc.subject.otherIndex |
protein expression |
dc.subject.otherIndex |
upregulation |
dc.subject.otherIndex |
Blood Cells |
dc.subject.otherIndex |
Bone Marrow Cells |
dc.subject.otherIndex |
Cell Differentiation |
dc.subject.otherIndex |
Cell Line, Tumor |
dc.subject.otherIndex |
Cyclooxygenase 1 |
dc.subject.otherIndex |
Cyclooxygenase 2 |
dc.subject.otherIndex |
Dinoprostone |
dc.subject.otherIndex |
Granulocytes |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Isoenzymes |
dc.subject.otherIndex |
Leukemia |
dc.subject.otherIndex |
Leukemia, Promyelocytic, Acute |
dc.subject.otherIndex |
Membrane Proteins |
dc.subject.otherIndex |
Myelopoiesis |
dc.subject.otherIndex |
Prostaglandin-Endoperoxide Synthases |
dc.subject.otherIndex |
RNA, Messenger |
dc.subject.otherIndex |
Tretinoin |
dc.subject.otherIndex |
Tumor Cells, Cultured |
dc.subject.otherIndex |
Up-Regulation |
dc.subject.otherKeywordPlus |
TRANS-RETINOIC ACID |
dc.subject.otherKeywordPlus |
PROSTAGLANDIN-G-H SYNTHASE |
dc.subject.otherKeywordPlus |
COLONY-FORMING CELLS |
dc.subject.otherKeywordPlus |
HL-60 CELLS |
dc.subject.otherKeywordPlus |
MYELOID DIFFERENTIATION |
dc.subject.otherKeywordPlus |
THROMBOXANE SYNTHESIS |
dc.subject.otherKeywordPlus |
HUMAN NEUTROPHILS |
dc.subject.otherKeywordPlus |
MONOCYTIC CELLS |
dc.subject.otherKeywordPlus |
RAR-ALPHA |
dc.subject.otherKeywordPlus |
EXPRESSION |
dc.subject.otherWOS |
Oncology |
dc.subject.otherWOS |
Hematology |